Select Publications
Journal articles
2024, 'Defining the correlates of lymphopenia and independent predictors of poor clinical outcome in adults hospitalized with COVID-19 in Australia', Scientific Reports, 14, http://dx.doi.org/10.1038/s41598-024-61729-5
,2024, 'Intensive care unit admission criteria: a scoping review', Journal of the Intensive Care Society, 25, pp. 296 - 307, http://dx.doi.org/10.1177/17511437241246901
,2024, 'What to Measure in Aneurysmal Subarachnoid Haemorrhage Research—An International Delphi Survey', Translational Stroke Research, http://dx.doi.org/10.1007/s12975-024-01271-8
,2023, 'Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia', PLoS ONE, 18, http://dx.doi.org/10.1371/journal.pone.0289907
,2023, 'Haptoglobin Treatment for Aneurysmal Subarachnoid Hemorrhage: Review and Expert Consensus on Clinical Translation', Stroke, 54, pp. 1930 - 1942, http://dx.doi.org/10.1161/STROKEAHA.123.040205
,2023, 'Mortality and costs related to severe acute pancreatitis in the intensive care units of Australia and New Zealand (ANZ), 2003–2020', Pancreatology, 23, pp. 341 - 349, http://dx.doi.org/10.1016/j.pan.2023.04.006
,2023, 'Fire in the belly: A scoping review of the immunopathological mechanisms of acute pancreatitis', Frontiers in Immunology, 13, http://dx.doi.org/10.3389/fimmu.2022.1077414
,2022, 'Prioritizing outcome measures after aneurysmal subarachnoid hemorrhage: A q-sort survey of patients, health care providers and researchers', Frontiers in Neurology, 13, http://dx.doi.org/10.3389/fneur.2022.1068499
,2022, 'Frontline workers: Mediators of mucosal immunity in community acquired pneumonia and COVID-19', Frontiers in Immunology, 13, http://dx.doi.org/10.3389/fimmu.2022.983550
,2022, 'Made to measure—Selecting outcomes in aneurysmal subarachnoid hemorrhage research', Frontiers in Neurology, 13, http://dx.doi.org/10.3389/fneur.2022.1000454
,2020, 'The association between hyponatraemia and long-term functional outcome in patients with aneurysmal subarachnoid haemorrhage: A single centre prospective cohort study', Journal of Clinical Neuroscience, 78, pp. 353 - 359, http://dx.doi.org/10.1016/j.jocn.2020.06.003
,2019, 'Core outcomes for subarachnoid haemorrhage', The Lancet Neurology, 18, pp. 1075 - 1076, http://dx.doi.org/10.1016/S1474-4422(19)30412-0
,2019, 'A Systematic Review of Outcome Measures Employed in Aneurysmal Subarachnoid Hemorrhage (aSAH) Clinical Research', Neurocritical Care, 30, pp. 534 - 541, http://dx.doi.org/10.1007/s12028-018-0566-0
,2011, 'HIV vaccines: Progress to date', Drugs, 71, pp. 387 - 414, http://adisonline.com/drugs/Abstract/2011/71040/HIV_Vaccines__Progress_to_Date.2.aspx
,Preprints
2023, Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia, http://dx.doi.org/10.1101/2023.08.17.23293358
,